Akums Drugs and Pharmaceuticals Limited has intimated the National Stock Exchange of India Limited and BSE Limited about its scheduled participation in an investor/analysts meet. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will participate in the Antique Healthcare Investor Conference scheduled for August 25, 2026. The meeting will begin at 09:00 AM IST and will be conducted as a group meet. The meeting will be held in physical mode at Trident, BKC, Mumbai.
The company specifically stated that no unpublished price sensitive information pertaining to the company will be shared during the meet with analysts or investors. The disclosure notes that the schedule may be subject to change due to exigencies on the part of investors/analysts or the company.
A copy of this disclosure has been updated on the company's website at www.akums.in. The communication was digitally signed by Dharamvir Malik, Company Secretary & Compliance Officer, on August 13, 2026, at 15:01:15 IST.